The risks we watch — and how we manage each one.
Once a clinic and van reach steady-state census, this is a healthy, profitable business. The risks that matter are ordinary operating ones — contract speed, grant timing, hiring, and filling the schedule — and each has a practical mitigation built into the plan.
The biggest variable is timing — the early months before a unit reaches breakeven (~248 patients). We start revenue fast with in-clinic and telehealth buprenorphine under our existing license, and use grants to bridge the ramp. At steady state a clinic and van runs at roughly 27% margin, rising as we add sites.
Risk register
Each risk carries a likelihood and impact rating over the first 24 months, plus its mitigation. These are ordinary operating risks — grant timing, hiring, payer enrollment, census ramp, and capital. Click any column header to sort.
| Risk | Likelihood | Impact | Mitigation |
|---|---|---|---|
| Slow start to revenue. Grants and settlement money disburse on their own schedule, and a new unit takes time to fill its schedule, so early months can run below breakeven. | Med | Med | In-clinic and telehealth buprenorphine under our existing license produces a first claim in 4–8 weeks, before any grant or contract closes; grant draw-down bridges the ramp to breakeven (~248 patients). |
| Grant timing and award uncertainty. Any single grant can be delayed, trimmed, or lost — exposing a unit that leaned on one grant for its build. | Med | Med | Stack independent sources rather than bet on one: county settlement direct-share (fastest, 60–120 days), federal RCORP (due July 8, 2026), state SOR, and stackable HRSA/foundation grants. Grants fund the build; recurring billing funds the durable core, so no single award is load-bearing. |
| Hiring clinicians on time. The model needs prescribers, nursing, and behavioral-health staff in a tight labor market, and a vacant prescriber seat caps how many patients a unit can carry. | Med | Med | Lead with a nurse-practitioner prescriber plus a part-time addiction-medicine physician — a flexible, widely available pattern; telehealth lets one prescriber cover both clinic and van. We recruit ahead of each site and stage hiring to census so payroll tracks revenue. |
| Payer enrollment and credentialing delays. Medicaid/Medicare enrollment and credentialing take time, and claims can't be paid until they clear. | Med | Low | Start enrollment and credentialing on day one, parallel to build-out, owned by a dedicated revenue-cycle specialist; grant funding covers uninsured care in the interim, so patients are seen from week one regardless. |
| Census ramp slower than planned. If referrals build slowly, a unit takes longer to reach the ~340-patient steady state and its early margin is thinner. | Med | Med | The van extends reach and feeds the clinic, and data-driven county targeting points outreach where need and reimbursement are highest. Breakeven (~248) sits well below the 300–500 an established clinic carries, so the margin for error is wide and grants cover the gap while census builds. |
| Capital and capex. An outreach van runs ~$170–290K, plus clinic build-out and working capital for the ramp; under-capitalizing the launch would force a stop-start. | Low | Med | The van is grant-eligible (mobile-unit grant, county direct-share, or RCORP), so it largely comes off the books rather than out of equity. We size working capital to reach breakeven up front, and proven unit economics make each later site self-funding from operating profit. |
| Vehicle and field operations. A mobile unit adds fuel, maintenance, insurance, and downtime risk a fixed clinic doesn't carry. | Low | Low | Vehicle costs are fully budgeted in the P&L (fuel, insurance, maintenance, registration), several lines grant-coverable. The van extends a fixed clinic rather than standing alone, so any downtime falls back to in-clinic and telehealth care without interrupting revenue. |
| Adding sites faster than the team can absorb. Scaling too quickly could strain shared functions (technology, billing, governance) and dilute quality. | Low | Med | Scale deliberately: prove one clinic + van first, then a handful, then a multi-county network. The CTO and data team are a shared cost the first site already absorbs, so each added site shares it — margin rises from ~27% toward ~38% rather than stretching the team thin. |
verify Likelihood and impact ratings are the team's planning estimates over a 24-month horizon — judgment calls, not measured probabilities.
Why the plan is resilient by design
The structure of the plan is itself the mitigation. Four choices keep the business steady through the ramp and as it scales.
Bill in weeks, not quarters
Buprenorphine under our existing license produces a first claim in 4–8 weeks — before any grant or contract closes — so the unit earns while it ramps.
No single point of failure
Independent grants fund the build and bridge the ramp; recurring Medicaid/Medicare billing funds the durable core. No single award has to land on time for the unit to work.
Breakeven well below capacity
Breakeven sits at ~248 patients against a 300–500 typical census. That gap is the buffer: a slower ramp costs time, not the business, and grants cover the months below it.
Shared cost, climbing margin
The technology and data team are a fixed cost the first site fully absorbs. Each added site shares it, so margin climbs from ~27% toward ~38% — scale makes the business stronger, not riskier.
The risks here are the ordinary ones of standing up and growing a clinical business — timing, hiring, enrollment, ramp, and capital — each with a practical mitigation already in the plan. We earn revenue from licensed care in weeks, use stacked grants to fund the build and bridge the ramp, and reach a profitable steady state whose margin improves with scale. See the financial model for the P&L, the capital plan for funding and grant coverage, and the roadmap for phase sequencing.